Deutsche Bank Upgrades Abbott Laboratories To Buy

Analysts at Deutsche Bank upgraded Abbott Laboratories

from Hold to Buy. The price target for Abbott Laboratories has been raised from $42.00 to $54.00. Abbott Laboratories shares have gained 15.05% over the past 52 weeks, while the S&P 500 index has surged 12.58% in the same period. Abbott Laboratories' shares rose 0.62% to close at $42.50 yesterday.